Robbins Arroyo LLP: Salix Pharmaceuticals, Ltd. (SLXP) Misled Shareholders According to a Recently Filed Class Action
12. November 2014 19:05 ET
|
Robbins LLP
SAN DIEGO and RALEIGH, N.C., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Salix Pharmaceuticals, Ltd. (Nasdaq:SLXP) has filed a...
Deadline in Lawsuit for Investors in Salix Pharmaceuticals, Ltd. (SLXP) Shares Announced by Shareholders Foundation
10. November 2014 09:30 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, Nov. 10, 2014 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Salix Pharmaceuticals, Ltd. (SLXP) over...
RedHill Biopharma Reports Results for the First Quarter of 2014
30. April 2014 11:00 ET
|
RedHill Biopharma Ltd.
Key financial highlights include:
A first profitable quarter, with net income of $3.4 million, primarily attributed to the $7 million upfront payment received from Salix Pharmaceuticals as part...
RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill's RHB-106 Encapsulated Bowel Preparation
27. Februar 2014 08:01 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Salix Pharmaceuticals Ltd. (Nasdaq:SLXP) and RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) today announced that they have entered into an...